⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRO News
Spero Therapeutics, Inc. Common Stock
International Avocado Day: Innovative Certification Program Covers More Than 90% of Mexican Avocados Exported to US
prnewswire.com
FDP
COST
SPRO
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer
globenewswire.com
SPRO
Form 8-K
sec.gov
SPRO
Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties
globenewswire.com
SPRO
KKR
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
globenewswire.com
SPRO
Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
prnewswire.com
SPRO
Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors
globenewswire.com
SPRO
The Eye Drink Achieves Verified Brand Status on RangeMe, Expanding Visibility to Retail Buyers Nationwide
accessnewswire.com
WMT
CVS
NDSN
SPRO
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
globenewswire.com
CMPS
SPRO